Why Are Hillstream BioPharma Shares Trading Over 100 percent Today?
| HILSDelisted Stock | USD 0.39 0.01 2.50% |
Slightly above 62% of Hillstream Biopharma's investor base is looking to short. The analysis of current outlook of investing in Hillstream Biopharma suggests that many traders are alarmed regarding Hillstream Biopharma's prospects. Hillstream Biopharma's investing sentiment can be driven by a variety of factors including economic data, Hillstream Biopharma's earnings reports, geopolitical events, and overall market trends.
Hillstream |
Hillstream BioPharma Inc signed an exclusive option agreement with Dana-Farber Cancer Institute to license technology targeting the MUC1-C oncoprotein. The MUC1 gene was identified by Dr. Donald Kufe, Physician and Researcher at Dana-Farber, based on its overexpression in human cancers. Dr. Kufe has demonstrated that MUC1-C is necessary for multiple cancer cell hallmarks. Dana-Farber has granted under an exclusive option agreement to Hillstream Biopharma Inc certain of its proprie
Read at finance.yahoo.com
 |
Hillstream Biopharma Fundamental Analysis
We analyze Hillstream Biopharma's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Hillstream Biopharma using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Hillstream Biopharma based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Net Income
Net Income Comparative Analysis
Hillstream Biopharma is currently under evaluation in net income category among its peers. Net income is the profit of a company for the reporting period, which is derived after taking revenues and gains and subtracting all expenses and losses. Net income is one of the most-watched numbers by money managers as well as individual investors.
Hillstream Biopharma Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Hillstream Biopharma stock to make a market-neutral strategy. Peer analysis of Hillstream Biopharma could also be used in its relative valuation, which is a method of valuing Hillstream Biopharma by comparing valuation metrics with similar companies.
Peers
Hillstream Biopharma Related Equities
| ZVSA | ZyVersa Therapeutics | 24.58 | ||||
| VRAX | Virax Biolabs | 3.42 | ||||
| PALI | Palisade Bio | 4.98 | ||||
| KPRX | Kiora Pharmaceuticals | 5.63 | ||||
| QNRX | Quoin Pharmaceuticals | 6.06 | ||||
| IMMX | Immix Biopharma | 6.67 | ||||
| CDIO | Cardio Diagnostics | 8.22 | ||||
| REVB | Revelation Biosciences | 8.62 | ||||
| UNCY | Unicycive Therapeutics | 10.81 |
Check out Risk vs Return Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of economic analysis. You can also try the Funds Screener module to find actively-traded funds from around the world traded on over 30 global exchanges.
Other Consideration for investing in Hillstream Stock
If you are still planning to invest in Hillstream Biopharma check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Hillstream Biopharma's history and understand the potential risks before investing.
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings |